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Summary
Constructing novel biological systems that function in a robust and predictable manner requires better
methods for discovering new functional molecules and for optimizing their assembly in novel
biological contexts. By enabling functional diversification and optimization in the absence of detailed
mechanistic understanding, directed evolution is a powerful complement to ‘rational’ engineering
approaches. Aided by clever selection schemes, directed evolution has generated new parts for
genetic circuits, cell-cell communication systems, and non-natural metabolic pathways in bacteria.
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Introduction
The emerging field of synthetic biology promises useful fuels and chemicals, sensors,
pharmaceuticals, therapies and materials as well as increased understanding of natural
biological systems. To rationalize the time-consuming, ad hoc construction of new biological
systems [1], some researchers advocate efforts to ‘standardize’ biological parts in such a way
that their behavior in novel assemblies or environments becomes more predictable [2]. The
notorious complexity and context-dependency of the behavior of biological parts and their
assemblies, however, makes such standardization extremely challenging. It is unlikely, in fact,
that biological parts can ever be fully standardized, and engineering methods that enable rapid
optimization of synthetic biological systems will be very useful. Evolution is Nature's
optimization algorithm; it is also the mechanism by which all the natural biological parts were
generated. Here we will discuss how evolution in the laboratory—directed evolution—supports
synthetic biology efforts, both in the generation of new parts and in the optimization of their
assemblies.
Genome sequencing efforts have provided an enormous number of sequences that encode new
biological parts. Unfortunately, a sequence only provides a hint as to its detailed biological
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properties, and the vast majority of these parts remain uncharacterized, much less standardized.
Furthermore, these parts are all from the large but nonetheless limited set of biologically
relevant ones. Many synthetic biology applications will require parts that are not biologically
relevant, parts that solve human problems and not necessarily problems for the organisms that
make them. An alternative to culling parts from natural sources is to construct them in the
laboratory. In many cases it may be more efficient to start from a well-characterized part, e.g.
an enzyme or a transcription factor, and engineer it to exhibit new properties than to try to find
the exact desired sequence in Nature. By tuning one property, for example ligand-binding
specificity, without dramatically changing others (e.g. ability to be expressed in a particular
host organism), this approach can in principle generate families of parts that differ along one
desired dimension but whose behaviors along others are at least similar and are therefore more
likely to be predictable. Ellis et al. demonstrated this very nicely by generating a library of
promoters and using them to construct feed-forward networks with different, predictable input-
output characteristics [3]. The diverse families of biological molecules that exist in Nature
were all generated by evolution. Not surprisingly, directed evolution—iterations of
mutagenesis and artificial selection or screening—can be an efficient way to generate new
biological parts in the laboratory [4,5].
The next step is assembly into circuits or pathways. Unfortunately, novel arrangements or
contexts can significantly affect how these molecules perform, and these effects are very
difficult to predict. In addition to its role in creating new functional molecules, evolution also
plays the role of Chief Editor in nature, turning disjoint paragraphs into great literature. In
synthetic biology, however, natural evolution is tremendously destructive, relentlessly
chipping away at painstakingly engineered networks and allowing the organism to escape
control. Nonetheless, evolution can be very helpful when tamed. Thus directed evolution can
be used to discover mutations that fine-tune circuits and pathways and optimize their
performance, all without requiring a detailed understanding of the mechanisms by which those
improvements are achieved.
This review covers recent applications of directed evolution in synthetic biology. The
discussion is limited to bacterial systems, where directed evolution experiments are relatively
easy to perform. Applications have included modifying protein transcription factors,
constructing synthetic genetic regulatory and cell-cell communication circuits, and engineering
enzymes for non-natural metabolic pathways. Some future challenges and opportunities for
directed evolution in synthetic biology are also discussed.
Engineering protein transcription factors
A significant fraction of synthetic biology research has focused on construction of synthetic
genetic circuits based on transcriptional regulators. The goal is to program cellular behavior
in both time and space, which extends genetic engineering to a much richer set of behaviors
and may provide a better understanding of how much more complex natural circuits work. The
construction of simple biological devices in bacteria, such as toggle switches, pulse generators,
and oscillators, as well as ‘minimal circuits’ that aim to reconstruct specific biological
functions, has relied largely on a very limited number of well-studied transcription factors:
LacI, TetR, AraC, LuxR, and λCI [6]. The construction of more complex circuits will require
a larger set of parts to choose from. Because ‘wiring’ in biological circuits occurs through
chemical binding specificity, these transcription factors will need to respond to diverse
signaling molecules and activate or repress transcription at diverse DNA sequences. While
there are a few reports of novel functions that have been engineered rationally into transcription
factors [7], designing a protein that can bind a chemical signal, transmit that signal into a
conformational change that alters DNA binding and regulates transcription is extremely
challenging. A very high degree of modularity has significantly simplified the problem for
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eukaryotic signaling pathways [8,9]; many bacterial transcription factors, however, do not
exhibit the same degree of modularity and appear far more difficult to modify.
The E. coli transcription factor AraC is widely used in combination with the PBAD promoter
for arabinose-inducible gene expression in bacteria. Unfortunately, crosstalk in the form of
inhibition of the AraC- PBAD system by IPTG prevents its use in combination with the popular
LacI-Plac system over the full range of inducer concentrations. Directed evolution improved
the compatibility of these systems by increasing the AraC system's sensitivity to arabinose 10-
fold, which also reduced its sensitivity to inhibition by IPTG and therefore crosstalk between
the two [10]. The binding specificity of AraC has also been altered by random mutagenesis of
specific residues of the binding pocket followed by FACS-based dual screening to identify
variants that respond to D-arabinose and not the native effector L-arabinose [11•].
Acyl-homoserine lactone (AHL)-based quorum sensing (QS) systems from bacteria have been
an important source of transcription factors for synthetic cell-cell communication circuits.
These systems consist of a signal synthase, which produces a diffusible signal, and a receptor
protein, which binds to the signal and activates transcription at a specific promoter. The well-
studied QS transcription factor LuxR, from Vibrio fischeri, has been a target for directed
evolution. Random mutagenesis and dual selection were used to switch the specificity of LuxR
so that it responds to decanoyl-homoserine lactone rather than the native 3-oxo-hexanoyl-
homoserine lactone signal [12]. This work demonstrated the utility of dual selection for
identifying variants of transcription factors that could respond to new signals and no longer to
the native ones. LuxR sensitivity to its native signal was also increased using directed evolution
[13]. In addition, these authors demonstrated how artificial positive feedback loops can increase
the effective sensitivity of LuxR-based circuits. The signal synthase component of QS systems
has also been engineered: the substrate specificity of the RhlI synthase was modified to increase
production of the non-native signal hexanoyl-homoserine lactone [14].
These successes notwithstanding, efforts to direct the evolution of protein transcription factors
have all been limited to conferring the ability to respond to new signaling molecules that are
closely related to the native signals. Large changes in a signal that elicits a regulatory response
have not been achieved, at least yet. DNA binding specificity appears to be similarly difficult
to modify in these proteins. No code for DNA binding has been deduced. One recent study
reported some success in using comparative genomic data to guide changes in DNA-binding
specificity, but unanticipated activation between non-cognate protein-operator pairs was also
frequently found [15]. In our experience, significant changes in ligand- and DNA-binding
functions are difficult to obtain, at least in the LuxR family of transcriptional activators. There
may be inherent limitations to transcription factor engineering, particularly when ligand
binding, DNA binding, and interaction with RNA polymerase and other transcription factors
are coupled through protein conformational changes. Mutations that alter one property often
have negative effects on another, and there may simply be fewer single mutations that lead to
measurable improvements in overall function when sub-functions are coupled.
Protein engineers may be able to glean useful information about choosing evolvable scaffolds
by looking at natural evolutionary history. A recent analysis of genome sequence data, for
example, showed uneven evolutionary expansion of different families of transcription factors
along the human lineage: the number of zinc finger proteins increased at several stages, while
the number of helix-loop-helix proteins has not significantly changed since originating in
metazoans [16]. Evolution and functional diversification is clearly much easier in modular
systems. In any case, much more work will have to be done to develop synthetic systems that
can respond to diverse ligands and regulate gene expression at diverse DNA sites. In addition
to their utility for constructing complex regulatory and cell-cell communication circuits, such
proteins will be useful as biosensors and in the regulation of novel metabolic pathways.
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Construction of synthetic genetic circuits
The construction of synthetic gene circuits is hampered by our inability to accurately predict
both the behavior of components placed in a new biological context and overall system
behavior, which can be highly nonlinear and dependent on stochastic fluctuations, or
“molecular noise”. While natural evolution readily takes care of such design problems, the
explosive growth in mutational possibilities with increasing sequence length and our limited
ability to screen or select for desired functions make this a challenge for directed evolution.
Combining mathematical modeling and directed evolution can greatly reduce this
combinatorial complexity [17]. Systematic perturbation of system components and
characterization of system behavior can allow the construction of a good predictive model with
a relatively small number of perturbations. Model analysis then allows identification of the
component(s) whose modification is most likely to lead to the desired function, significantly
reducing the search space for directed evolution (Figure 1). Alternatively, having a library of
tuned components already at hand allows rapid fine-tuning of circuit function, particularly with
the aid of a validated mathematical model of the system [3].
In an early example of the directed evolution approach, random mutagenesis of one protein
component rescued a circuit that was non-functional due to mismatches in the activities or
concentrations of chemicals that ‘wire’ one component to the next [18]. A similar approach
was used recently to generate a genetic AND gate using LuxR and LacI [14]. Ribosome binding
sites (RBS) are good targets for tuning mismatches in component activities. In a nice example,
a modular AND gate was constructed using two inputs to drive expression of an amber
suppressor tRNA and a T7 RNA polymerase gene modified to contain two amber codons
[19]. The initial construct did not function as an AND gate, but saturation mutagenesis of the
RBS and screening the resulting clones identified functional circuits. Targeting the RBS greatly
reduces the experiment complexity—this RBS library contained only ∼128 variants.
Directed evolution is likely to be extremely useful for identifying functional circuits and tuning
their performance. Fluorescent protein gene expression reporters allow reasonably simple
functional screening [11•], and selections based on antibiotic resistance are also generally
accessible [12].
Engineering non-native metabolic pathways
An exciting challenge for synthetic biology is establishing and optimizing non-native, and
sometimes non-natural, metabolic pathways in various host microorganisms for the production
of fuels, bulk chemicals, specialty chemicals, and pharmaceuticals. New molecular biology
tools and fast, inexpensive DNA synthesis methods represent significant improvements to the
genetic engineering toolbox and have allowed synthetic biologists to rapidly generate,
characterize, and optimize new enzymes for these applications [20,21•]. Biosynthesis offers
significant advantages in terms of reaction selectivity, waste reduction and the ability to use
inexpensive feedstocks such as plant sugars, but these applications require significant
optimization in terms of enzyme function, timing of gene expression, and balancing of
metabolic fluxes in order to be cost-competitive with chemical processes [22].
Directed evolution has been very useful for improving enzymes in engineered metabolic
pathways. It has also been used to engineer new activities and establish whole new routes to
chemicals with the potential for higher yields and/or fluxes. The microbial shikimate pathway
is interesting for the production of a variety of chemicals traditionally produced from
petroleum-derived benzene [23•]. Competition for phosphoenolpyruvate (PEP) between the
phosphotransferase (PTS) system of E. coli and 3-deoxy-D-arabino-heptulosonic acid 7-
phosphate (DAHP) synthase, a key enzyme in the shikimate pathway, limits the theoretical
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yield of shikimic acid that can be derived from glucose. A creative strategy for alleviating this
limitation involves replacing DAHP synthase with an enzyme that would produce DAHP by
condensing D-erythrose 4-phosphate and pyruvate rather than PEP (Figure 2). The low activity
of E. coli 2-keto-3-deoxy-6-phosphogalactonate (KDPGal) aldolase for this key reaction was
enhanced by directed evolution, where the enzyme's ability to support growth of a DAHP-
deficient strain in the absence of aromatic amino acids was used to identify improved variants
[23•]. Although this experiment clearly established this new pathway, the observed 60-fold
increase in kcat/KM was not sufficient to improve shikimic acid production relative to an
optimized strain that used DAHP synthase.
An exciting development in the field of biofuels is a route to production of higher alcohols in
E. coli using the 2-keto acid intermediates from branched-chain amino acid biosynthesis
[24•]. Initial work demonstrated the feasibility of making isobutanol, 1-butanol, 2-methyl-1-
butanol, 3-methyl-1-butanol and 2-phenylethanol from glucose; more recent work has focused
on optimizing the pathways for production of specific alcohols. In one example, directed
evolution of citramalate synthase (CimA) from Methanococcus jannaschii, which in
combination with two E. coli enzymes allows the intermediate 2-ketobutyrate to be produced
directly from pyruvate, improved 1-propanol and 1-butanol production 10-20 fold. The
selection took advantage of the isoleucine auxotrophy of an E. coli ilvA tdcB mutant to identify
CimA variants that improved flux through the alternate 2-ketobutyrate pathway [24•]. In
contrast, a structure-guided approach was used to engineer improved variants of 2-
ketoisovalerate decarboxylase and 2-isopropylmalate synthase which increased the production
of 5-8 carbon alcohols [25•]. This pair of papers nicely illustrates that there is no one-size-fits-
all approach to engineering non-natural metabolic pathways; both directed evolution and
rational design will be useful.
Natural products produced by non-ribosomal peptide synthetases (NRPS) and polyketide
synthases (PKS) are a rich source of important pharmaceuticals. The chemical diversity
generated by such enzyme complexes can be expanded beyond that of known natural pathways
by engineering the complexes. One approach has been to swap genes between NRPSs to
generate chimeras that produce new variations of the natural product. Chimeras produced in
this way, however, frequently have little or no activity. But recent work has demonstrated that
directed evolution can quickly improve chimera activity, even with modest library sizes and
limited screening [26•]. Subjecting two chimeric NRPSs to random mutagenesis by error-prone
PCR achieved ∼10-fold improvements in activity with 3 or fewer rounds of screening
(103-104 clones). The availability of a suitable high-throughput assay (or selection) with which
to screen mutant libraries is critical for directed evolution. Lee and Khosla engineered a strain
of E. coli that produced small amounts of the macrolide 6-deoxyerythromycin D and then used
a colony-based bioassay to identify mutant bacteria which produced more of the antibiotic
[27].
Directed evolution has been widely used to improve activities and discover novel activities in
a wide range of enzymes. Any of these is potentially a part for a new non-natural metabolic
pathway, limited only by the creativity of the synthetic biologist. For example, many useful
natural products are glycosylated, and the identity and position of sugar moieties often have
large effects on a given compounds pharmacological properties. The field has lacked general
tools for diversifying glycosylation of natural products, but Williams et al. described the
engineering of a promiscuous glycosyltransferase that accepts a wide variety of sugar substrates
[28•]. Three rounds of mutagenesis and a high-throughput screen using a fluorescent surrogate
substrate were used to identify a variant of the oleandomycin glycosyltransferase capable of
transferring a variety of sugar substrates to diverse relevant acceptor molecules, including
macrolides, flavonoids, and coumarins. This group later used information from the screen to
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identify targets for saturation mutagenesis, allowing further improvements in activity on a
therapeutically relevant substrate, novobiocic acid [29].
Conclusions
Directed evolution is a powerful optimization and engineering strategy for synthetic biology,
but it is important to understand its limitations. Success requires that there exist an incremental
pathway of beneficial mutations to the desired function and a good screening or selection
strategy to identify it. Mathematical modeling can identify appropriate targets for optimization,
dramatically reducing the search space for optimization. Many enzymes have proven to be
remarkably evolvable, and this plasticity of function has been exploited to establish whole new
biosynthetic pathways to fuels and chemicals. The more modest successes reported with
engineered transcription factors may reflect inherent limitations to their evolvability, or it may
simply reflect the much lower level of effort devoted to engineering them. The ease of coupling
the function of transcription factors to widely-available fluorescent protein reporters or to cell
growth, however, offer significant advantages for their directed evolution. Biological parts
evolved in bacteria can often be incorporated directly into pathways and circuits constructed
in higher organisms. While directed evolution in yeast is straightforward and indeed offers
some advantages [30], extension of evolutionary methods to other bacteria and higher
organisms is limited mainly by the genetic tools available, particularly the ability to make large
libraries of variants and by the longer time-scales for cell growth. Novel in vivo evolution
methods may overcome some of these hurdles in the future [31].
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Synthetic gene circuits frequently do not function as designed due to mismatches in component
properties. Mathematical modeling combined with directed evolution can rapidly tune circuit
performance. For example, the sensitivities of two transcription factors to individual inputs
can be tuned to generate a functional AND gate from a non-functional circuit.
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Directed evolution can be used to generate novel metabolic routes to useful chemicals. A
phosphoenolpyruvate (PEP)-independent route (shown in black) to the key intermediate, 3-
deoxy-D-arabino-heptulosonic acid 7-phosphate (DAHP), was engineered by using directed
evolution to enhance a weak DAHP-synthesizing activity present in 2-keto-3-deoxy-6-
phosphogalactonate (KDPGal) aldolase [23•]. The original route using DAHP synthase is
shown in gray.
Dougherty and Arnold Page 10
Curr Opin Biotechnol. Author manuscript; available in PMC 2010 August 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
